Centessa Pharmaceuticals plc
NASDAQ:CNTA
15.81 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||
| Current Assets: | |||||||||||||||
| Cash & Cash Equivalents
| 127.372 | 118.218 | 128.03 | 171.498 | 145.22 | 259.988 | 393.644 | 444.843 | 484.161 | 544.465 | 595.082 | 578.815 | 613.759 | 298.612 | 7.227 |
| Short Term Investments
| 167.461 | 111.959 | 128.519 | 109.843 | 158.367 | 86.241 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 294.833 | 230.177 | 256.549 | 281.341 | 303.587 | 346.229 | 393.644 | 444.843 | 484.161 | 544.465 | 595.082 | 578.815 | 613.759 | 298.612 | 7.227 |
| Net Receivables
| 46.993 | 37.175 | 39.148 | 30.391 | 28.423 | 23.394 | 26.723 | 21.706 | 21.798 | 23.143 | 16.814 | 21.556 | 15.304 | 12.954 | 0 |
| Inventory
| 0 | 0 | 0 | 17.862 | 14.534 | 11.58 | -29.994 | 9.153 | 12.395 | 12.467 | -17.807 | 10.224 | 14.175 | 1.388 | 0 |
| Other Current Assets
| 13.676 | 17.124 | 19.395 | 2.859 | 3.869 | 3.127 | 3.271 | 1.288 | 1.144 | 1.12 | 0.993 | 1.05 | 0.444 | 0.682 | 3.938 |
| Total Current Assets
| 355.502 | 284.476 | 315.092 | 332.453 | 350.413 | 384.33 | 393.644 | 476.99 | 519.498 | 581.195 | 595.082 | 611.645 | 643.682 | 313.636 | 11.165 |
| Non-Current Assets: | |||||||||||||||
| Property, Plant & Equipment, Net
| 12.374 | 12.646 | 12.953 | 13.232 | 13.487 | 13.49 | 1.168 | 0.552 | 0.905 | 0.374 | 0.162 | 0.114 | 0.075 | 0.045 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 28.588 | 29.166 | 32.37 | 29.577 | 26.754 | 0 | 3.512 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 2.381 | 1.883 | 2.554 | 2.102 | 2.267 | 6.04 | 45.983 | 1.813 | 0.648 | 0.619 | 34.391 | 0.448 | 0 | 6.839 | 0.552 |
| Total Non-Current Assets
| 43.343 | 43.695 | 47.877 | 44.911 | 42.508 | 19.53 | 50.663 | 2.365 | 1.553 | 0.993 | 34.553 | 0.562 | 0.075 | 6.884 | 0.552 |
| Total Assets
| 398.845 | 328.171 | 362.969 | 377.364 | 392.921 | 403.86 | 444.307 | 479.355 | 521.051 | 582.188 | 629.635 | 612.207 | 643.757 | 320.52 | 11.717 |
| Liabilities & Equity: | |||||||||||||||
| Current Liabilities: | |||||||||||||||
| Account Payables
| 5.32 | 7.499 | 11.815 | 10.848 | 11.085 | 14.368 | 13.836 | 10.858 | 8.229 | 6.689 | 8.065 | 18.456 | 7.261 | 12.216 | 1.032 |
| Short Term Debt
| 0.552 | 0.528 | 0 | 0.482 | 0.46 | 0.398 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.627 |
| Tax Payables
| 0 | 0 | 0.112 | 0 | 0 | 2.123 | 1.582 | 0 | 0 | 0.769 | 0.769 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 23.465 | 21.815 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 20.883 | 19.408 | 27.57 | 0.159 | 0.507 | 14.92 | 24.502 | 27.333 | 25.34 | 20.505 | 16.573 | 10.688 | 16.924 | 6.761 | 1.96 |
| Total Current Liabilities
| 26.755 | 27.435 | 39.385 | 34.954 | 33.867 | 29.686 | 38.338 | 38.191 | 33.569 | 27.194 | 24.638 | 29.144 | 24.185 | 18.977 | 8.619 |
| Non-Current Liabilities: | |||||||||||||||
| Long Term Debt
| 76.5 | 76.8 | 75.7 | 83.02 | 82.448 | 80.913 | 69.8 | 68.2 | 67.4 | 74.8 | 75.7 | 0 | 0 | 0.291 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 8.888 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 2.723 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 8.625 | 8.773 | 0.029 | 0 | 0 | 0 | 38.338 | 0.043 | 0.043 | 0.043 | 62.381 | 33.93 | 33.93 | 22.618 | 0 |
| Total Non-Current Liabilities
| 85.125 | 85.573 | 87.34 | 83.02 | 82.448 | 80.913 | 108.138 | 68.243 | 67.443 | 74.843 | 138.081 | 33.93 | 33.93 | 22.909 | 0 |
| Total Liabilities
| 111.88 | 113.008 | 126.725 | 117.974 | 116.315 | 110.599 | 108.138 | 106.434 | 101.012 | 102.037 | 138.081 | 63.074 | 58.115 | 41.886 | 8.619 |
| Equity: | |||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 247.847 | 0 |
| Common Stock
| 0.309 | 0.277 | 0.273 | 0.271 | 0.266 | 0.266 | 0.265 | 0.263 | 0.263 | 0.262 | 0.252 | 0.252 | 0.252 | 0.133 | 25.546 |
| Retained Earnings
| -834.807 | -790.991 | -752.945 | -716.108 | -677.46 | -652.574 | -601.86 | -558.687 | -504.812 | -440.151 | -385.653 | -324.879 | -284.724 | -243.273 | -23.845 |
| Accumulated Other Comprehensive Income/Loss
| 1.595 | 1.623 | 1.493 | 0.779 | 0.946 | -0.599 | -1.497 | -1.695 | -1.142 | -0.018 | 0.688 | 2.738 | 3.225 | 2.131 | 0.572 |
| Other Total Stockholders Equity
| 1,119.868 | 1,004.254 | 987.423 | 974.448 | 952.854 | 946.168 | 939.261 | 933.04 | 925.73 | 920.058 | 876.267 | 871.022 | 866.889 | 271.796 | 0.825 |
| Total Shareholders Equity
| 286.965 | 215.163 | 236.244 | 259.39 | 276.606 | 293.261 | 336.169 | 372.921 | 420.039 | 480.151 | 491.554 | 549.133 | 585.642 | 278.634 | 3.098 |
| Total Equity
| 286.965 | 215.163 | 236.244 | 259.39 | 276.606 | 293.261 | 336.169 | 372.921 | 420.039 | 480.151 | 491.554 | 549.133 | 585.642 | 278.634 | 3.098 |
| Total Liabilities & Shareholders Equity
| 398.845 | 328.171 | 362.969 | 377.364 | 392.921 | 403.86 | 444.307 | 479.355 | 521.051 | 582.188 | 629.635 | 612.207 | 643.757 | 320.52 | 11.717 |